Quality Factory Supply 53-43-0 with Competitive Price DHEA CAS NO.53-43-0
- FOB Price: USD: 230.00-230.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: T/T,Other
- Available Specifications:
Excellent(1-100)Kilogram
- Product Details
Keywords
- DHEA high purity
- favourable price of DHEA
- 53-43-0 wholesale
Quick Details
- ProName: favourable price of DHEA 53-43-0 hig...
- CasNo: 53-43-0
- Molecular Formula: C19H28O2
- Appearance: White fine powder
- Application: Medical Intermediate
- DeliveryTime: 2 Days
- PackAge: Drum or Aluminum Foil Bag
- Port: ShangHai
- ProductionCapacity: 200 Metric Ton/Month
- Purity: 99%MIN
- Storage: Cool and dry place
- Transportation: prompt delivery after payment confirme...
- LimitNum: 1 Kilogram
- Grade: Food Grade,Pharma Grade,Other
Superiority
favourable price of DHEA 53-43-0 high purity wholesale
Kono Chem Co.,Ltd is a leading producer of standardized herbal extracts, natural active ingredients and APIs for pharmaceutical, health food and cosmetic industries.
Annually, more than 3,000 tons of a wide range of herbal extracts and natural active substances are extracted at the Kono Chem Co.,Ltd manufacturing plant near Xi'an, China. These extracts are in compliance with worldwide GMP、HACCP norms, international Pharmacopoeias, and international regulations.
The botanical raw materials are subject to strict selection and inspection, and extracts are manufactured according to methods developed by Kono Chem. They include inspections to guarantee a high quality standard from both analytico-chemical and therapeutic points of view, and take into consideration the state of art in different fields: research and development, analyses, processes and machinery, therapeutic applications on a scientific basis.
With our phytopharmaceutical background and knowledge through experience, Kono Chem can also provide a wide range of analytical services and reference substances to our clients. In addition, We also manufacture pharmaceutical raw materials of nucleotide species, mainly including as below: SAM-e Tosylate Disulfate; SAM-e 1,4-Butanedisulfonate; Polycytidylic Acid; Polyinosinic Acid; Adenosine Triphosphate Disodium; and Cytidine Triphosphate Disodium; these items are our strongest advantage in China. Meanwhile, we can do custom made pharmaceutical ingredients depending on our professional experts in the pharmaceutical and chemistry industry.
Recently, Kono Chem has been working hard on the research and development of new cardiovascular and anesthesia drugs, we have got good achievements; moreover, we also offer natural anticancer drugs and other pharmaceutical intermediates. As a GMP standardized manufacturer, our products can meet or even exceed the standards of CP2010, USP32, BP2005 and EP4. Presently, 80% and above of our products have been well-recognized in dozens of countries and regions, such as USA, EU, South America and Southeast Asia. There are experienced technicians working for our institutes now, all of them are skilled. Pioneer is looking forward to cooperating with friends all over the world for getting collaborative development; we are willing to work with you to develop new drugs and expand new business, let's work together for bright future.
Process Capability : Suoer critical CO2 extraction method Fermentation expert Other synthesis service
After-sale Service : Prompt delivery in worldwide 24 hour online Goods return policy
Product Name |
Dehydroepiandrosterone |
Synonyms |
DHEA; Prasterone; Androstenolone; Dehydroisoandrosterone; trans-Dehydroandrosterone; Hydroxyandrost-5-en-17-one |
CAS NO. |
53-43-0 |
EINECS |
200-175-5 |
Molecular Formula |
C19H28O2 |
Molecular Weight |
288.43 |
Specifications: |
|
Standard |
Assay ≥99% |
Appearance |
White crystalline powder |
Melting Point |
146-151℃ |
Details
XI'AN KONO CHEM (XI'AN KONO CHEM) is a commitment to the development of pharmaceutical raw materials and intermediates in the production, management and plant extracts of the export trade suppliers in recent years, it and other Asian countries and Europe, the Americas, African countries have trade, our goal is to become an important domestic pharmaceutical and chemical raw materials exporters and the world's latest pharmaceutical raw materials importers.
Xi'an Connaught Chemical has been adhering to the company to market-oriented, customer-focused, with professional and enterprising spirit of the team and the company's strong financial strength, to provide customers with fast, high quality and efficient services, and always to "maximize Interests of customers "for the purpose.
In the pharmaceutical raw materials and intermediate export business, the company with more than 10 years of accumulated experience and high-quality and reasonable personnel structure, accurate grasp of the market, not only with a number of well-known domestic enterprises to establish a long-term and stable strategic cooperative relations in the global pharmaceutical Chemical raw materials and chemical intermediates on the market has also won a loyal customer base and a very strong strategic cooperation partners, establish a professional image of the procurement of medical outsourcing. On the basis of continuing to develop existing export business, the Company has formulated the idea of establishing an independent R & D center and building a production base of pharmaceutical and chemical products according to the future development trend of the pharmaceutical and chemical industry, and strives to establish a combination of R & D, manufacturing and trade. Of the business development model.
After years of development, after several polished, Panier biological has formed a highly competitive, cohesive and creative professional team, emerged more than the backbone of the business, the growth of enterprises at the same time achievements of each employee. At the same time a wealth of sports activities make rigorous, busy work process without losing the active atmosphere, simple, collaborative relationships create a harmonious and relaxed office environment.
While actively expanding its business and creating economic profit, the enterprise has not forgotten its social responsibility and actively participated in social activities such as afforestation and tree planting and poverty-stricken student education. It has been a tradition for many years and has created good social benefits.
Quality Factory Sells 53-43-0 with Competitive Price
- Molecular Formula:C19H28O2
- Molecular Weight:288.43
- Appearance/Colour:white fine crystalline powder
- Vapor Pressure:4.54E-09mmHg at 25°C
- Melting Point:149-151 °C(lit.)
- Refractive Index:1.56
- Boiling Point:426.7 °C at 760 mmHg
- PKA:15.02±0.60(Predicted)
- Flash Point:182.1 °C
- PSA:37.30000
- Density:1.12 g/cm3
- LogP:3.87920
Dehydroepiandrosterone(Cas 53-43-0) Usage
Indications and Usage |
Dehydroepiandrosterone (DHEA,) chemical name 3β-hydroxy-5alpha-androstane-17-ketone, is an esterifying 3–β–hydroxy steroid retaining 5,6 cholesterol. A white crystalline powder, soluable in ethanol, ether, and benzene, and slightly soluable in chroloform and petroleum ether. Precipitates in digitalis. DHEA is an estrogen precursor secreted by the reticular layer of the human adrenal cortex. Prevents obesity, resists diabetes, fights cancer, fights cortical disease, and delays senility treats immune deficiencies, promotes the growth and differentiation of bone cells, and promotes the synthesis of protein. It also resists viral infections, improves memory, and relieves nervous tension. DHEA is the main ingredient in steroid hormone intermediates (such as norethindrone and bisacetylene, etc.) and in birth control, and is involved in the secretion of many adrenal hormones. It has undergone extensive clinical research on treating menopausal syndrom, chorionitis, coronary heart disease, gout, psoriasis, AIDS and so on. |
Mechanisms of Action |
DHEA has a thyroid stimulating effect inhibiting food and fat intake and reducing fat accumulation, etc. It improves glucose tolerance, increases insulin level and fights diabetes. It can enhance endocrine system actiity, reduce cortisol levels, and resist a variety of pathological processes. It can help the body obtain cortical antibodies. DHEA has a strong protective and synergistic effect when used to treat tumors, becuase it inhibits ribose 5-phosphate. Inhibits cancer by inhibiting excessive mitochondria (NADPH) and ribose 5-phosphate esters. Regulates the growth of pancreatic cancer cells by regulating the concentration of estrogen in blood plasma. A decline in GnRH gene expression leads to aging, and DHEA can restore GnRH neuronal activity, stopping or improving certain diseases associated with declines in DHEA by stimulating GnRH biosynthesis. Restores impaired immune response, improves T- and B-cell function, and plays an important role in enhancing the physiological activity of insulin-like growth factor (IGF-1,) and is a potentially useful drug for immunodeficiency. DHEA alone cannot directly affect the growth and differential of osteoblasts, but it can do so by influencing 1,25-dihydroxyvitamin D3. The effects of DHEA on bone mass depend on the presence and form of sex hormones in bone cells and their endrocine effects on osteoblasts. DHEA is an anabolic protein hormone which promotes protein synthesis. According to the findings of Marrero and others, feeding DHEA (0.45%) to mice increased liver weight, increasing liver mitochondria by guiding liver protein restoring RNA and protein synthesis. |
Manufacturing Process |
To a solution of 1 gram of 16-dehydropregnenolon-3β-acetate in 10 ml pyridine is added 0.22 gram of hydroxylamine hydrochloride, and the mixture is allowed to stand at room temperature for four days. One gram of 16dehydropregnenolon-3β-acetate oxime is dissolved in 30 ml of hot dioxane, and then the solution is cooled in an ice bath until about one-half of the dioxane has solidified. Then 1 gram of phosphorus pentachloride is added and the mixture is shaken until all the dioxane has melted. The mixture is maintained at 35°C, for seventy-five minutes, then an excess of ice is added and the solution is again allowed to stand at 35°C. After about thirty minutes, a solution of 5 ml of concentrated hydrochloric acid in 10 ml of water is added, and the mixture is diluted with water, extracted with ether and the ethereal extract washed with dilute sodium hydroxide solution. The ether is removed on a steam bath and the residue is worked up to yield dehydroepiandrosterone. |
Therapeutic Function |
Glucocorticoid |
World Health Organization (WHO) |
The World Health Organization has no information further to the above regarding preparations containing prasterone or to indicate that such preparations remain available. |
Health Hazard |
An experimental teratogen.Experimental reproductive effects. Questionablecarcinogen with experimental neoplastigenic data. Whenheated to decomposition it emits acrid smoke andirritating fumes. |
Biochem/physiol Actions |
Product does not compete with ATP. |
Side effects |
Side effects may include acne, skin rash, GI upset, hirsuitism, hypertension, and increased HDL. In people with HIV, additional side effects may include fatigue, nasal congestion, and headaches. |
Safety |
Dehydroepiandrosterone should always be used under the supervision of a medical professional. It is likely safe for people with low DHEA levels to take oral supplements short-term (<6 months) to restore DHEA to normal, but long-term use and doses resulting in high DHEA levels are possibly unsafe. Side effects are often seen with higher doses and longterm use. |
references |
[1]. kimonides vg, khatibi nh, svendsen cn, et al. dehydroepiandrosterone (dhea) and dhea-sulfate (dheas) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. proc natl acad sci u s a, 1998, 95(4): 1852-1857.[2]. suzuki m, wright ls, marwah p, et al. mitotic and neurogenic effects of dehydroepiandrosterone (dhea) on human neural stem cell cultures derived from the fetal cortex. proc natl acad sci u s a, 2004, 101(9): 3202-3207.[3]. charalampopoulos i, tsatsanis c, dermitzaki e, et al. dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic bcl-2 proteins. proc natl acad sci u s a, 2004, 101(21): 8209-8214. |
Bone Loss Prevention |
Subsequent trials have examined prasterone as a treatment to limit bone loss in women with SLE. |
Investigation for Systemic Lupus Erythematosus (SLE) |
Prasterone, a synthetic dehydroepiandrosterone product, has been investigated for use in women with SLE who are taking glucocorticoids. Initial trials focused on improving disease activity and symptoms in women with mild to moderate SLE, but the FDA did not approve prasterone's labeling for these indications. |
Potential Drug Interactions |
Prasterone may interact with 5-alpha reductase inhibitors and exhibit additive or antagonistic effects with androgens, estrogens, oral contraceptives, and progestins. |
Dosage |
In clinical trials, oral prasterone dosages of 100鈥?200 mg/day were administered, resulting in supraphysiological hormone levels. |
Intravaginal Use |
Intravaginal prasterone, marketed as Intrarosa庐, is approved for the treatment of vulvar and vaginal atrophy (VVA) in postmenopausal women with moderate to severe symptoms. |
description |
Dehydroepiandrosterone (DHEA) is a steroid hormone that is a popular nonprescription oral “dietary supplement” used by men to enhance cognitive function, mood, libido, and athletic performance. Before 1994, DHEA was a prescription medicine. After the passage of the Dietary Supplement Health and Education Act of 1994, DHEA was reclassified as a nutritional supplement. Although sold over the counter in 25- and 50-mg strengths, DHEA is widely touted to maximize results at doses of 200 mg or higher. DHEA is banned by the International Olympic Committee and the National Collegiate Athletic Association as an anabolic agent. Limited information is available regarding potential harmful effects resulting from its supplemental use. |
Definition |
ChEBI: Dehydroepiandrosterone is an androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands. It has a role as an androgen, a human metabolite and a mouse metabolite. It is a 17-oxo steroid, an androstanoid and a 3beta-hydroxy-Delta(5)-steroid. |
Brand name |
17-chetovis 17-hormoforin;Cetavister;Climatost;Dastonil;Dha-s (prasterone);Gynodian;Longevital 5000;Maxepa;Mentalormon;Mylis;Neurocotex;Psicosterone;Ro 66827;Sh 833;Ultrapla. |
General Description |
DHEA is a major secretory steroidal product of the adrenal gland and is a hormonal precursor to both androgens and estrogens. It can also be synthesized using wild yam or soy, but there is no evidence to show that humans are able to increase DHEA levels by consuming these foods. DHEA and its sulfated metabolite, DHEA-S, are negative modulators of GABAA receptors. |
InChI:InChI=1/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15?,16?,18-,19-/m0/s1
53-43-0 Relevant articles
Synthesis and structure determination of 3β-hydroxyandrost-5-en-17-one (C19H28O2·CH3OH)
Verma, Rajnikant,Jasrotia, Dinesh,Sawhney, Anshu,Bhat, Mousmi,Gupta
, p. 523 - 528 (2004)
3β-Hydroxyandrost-5-en-17-one (C19H28O 2...
A steroidogenic pathway for sulfonated steroids: The metabolism of pregnenolone sulfate
Neunzig,Sánchez-Guijo,Mosa,Hartmann,Geyer,Wudy,Bernhardt
, p. 324 - 333 (2014)
In many tissues sulfonated steroids exce...
Isolation of new androstenol-3()-on-17 from the urine of a patient with
DINGEMANSE,HUIS IN T VELD,HARTOGH-KATZ
, p. 848 - 848 (1948)
-
Etherification of Hydroxystereoids via Triflates
Belostotskii, Anatoly M.,Hassner, Alfred
, p. 5075 - 5076 (1994)
Triflates of saturated alcohols are usef...
Modified bile acids and androstanes—Novel promising inhibitors of human cytochrome P450 17A1
Dzichenka, Yaraslau,Shapira, Michail,Yantsevich, Aliaksei,Cherkesova, Tatsiana,Grbovi?, Ljubica,Savi?, Marina,Usanov, Sergey,Jovanovi?-?anta, Suzana
, (2020/11/17)
Cytochromes P450 are key enzymes for ste...
Deconstructive Oxygenation of Unstrained Cycloalkanamines
Han, Bing,He, Yi-Heng,Pan, Jia-Hao,Wang, Yuan-Rui,Yu, Wei,Zhang, Jian-Wu
supporting information, p. 3900 - 3904 (2020/02/11)
A deconstructive oxygenation of unstrain...
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry
Correia, Mário S.P.,Ballet, Caroline,Meistermann, Hannes,Conway, Louis P.,Globisch, Daniel
, p. 955 - 962 (2019/02/09)
Sulfatases hydrolyze sulfated metabolite...
Method for preparing 4-androstenedione from dehydroepiandrosterone acetate
-
Paragraph 0026; 0027; 0028; 0032-0034; 0038-0040, (2019/07/04)
The invention provides a method for prep...
53-43-0 Process route

-
- 53-43-0
dehydroepiandrosterone

-
- 100-52-7
benzaldehyde
Conditions | Yield |
---|---|
|
-
- 63-05-8
Androstenedione

-
- 53-43-0
dehydroepiandrosterone
Conditions | Yield |
---|---|
Androstenedione; With titanium(IV) oxide; platinum; In toluene; at 100 ℃; for 3h;
With hydrogen; In toluene; for 8h; under 15001.5 Torr; Temperature; Reagent/catalyst; Pressure;
|
85% |
Multi-step reaction with 2 steps
1.1: potassium tert-butylate / tert-butyl alcohol / 1.5 h / 35 - 40 °C / Inert atmosphere
1.2: 20 - 25 °C
2.1: NADP; magnesium(II) chloride hexahydrate; alpha-D-glucopyranose; NAD+ / 2-methyltetrahydrofuran; aq. phosphate buffer / 20 - 32 °C / Enzymatic reaction
With alpha-D-glucopyranose; magnesium(II) chloride hexahydrate; potassium tert-butylate; NADP; NAD+; In 2-methyltetrahydrofuran; aq. phosphate buffer; tert-butyl alcohol;
|
|
Multi-step reaction with 2 steps
1: potassium tert-butylate / tert-butyl alcohol / 1 h / 30 - 35 °C / Inert atmosphere
2: D-glucose; NAD; glucose dehydrogenase (CDX-901)_; ketoreductase from Sphingomonas wittichii; potassium carbonate / ethyl acetate; aq. phosphate buffer / 21 h / 32.5 °C / pH 6.3 - 6.5 / Inert atmosphere; Enzymatic reaction
With D-glucose; glucose dehydrogenase (CDX-901)_; ketoreductase from Sphingomonas wittichii; potassium tert-butylate; NAD; potassium carbonate; In aq. phosphate buffer; ethyl acetate; tert-butyl alcohol;
|
|
Multi-step reaction with 4 steps
1: aluminum (III) chloride; 5-sulfosalicylic Acid / 5 h / 20 - 30 °C / Inert atmosphere; Large scale
2: orthoformic acid triethyl ester; boron trifluoride diethyl etherate / dichloromethane / 5 h / 20 - 30 °C / Inert atmosphere
3: calcium borohydride / dichloromethane / 15 h / -20 - -15 °C
4: toluene-4-sulfonic acid / acetone; water / 1 h / 45 - 50 °C / Inert atmosphere
With aluminum (III) chloride; calcium borohydride; boron trifluoride diethyl etherate; toluene-4-sulfonic acid; orthoformic acid triethyl ester; 5-sulfosalicylic Acid; In dichloromethane; water; acetone;
|
53-43-0 Upstream products
-
57-88-5
cholesterol
-
83-46-5
β-sitosterol
-
651-48-9
dehydroepiandrosterone sulfate
-
571-36-8
5-androstenedione
53-43-0 Downstream products
-
5419-51-2
3β-(2-tetrahydropyranyloxy)-5-androstene-17β-0l
-
566-19-8
3β-hydroxyandrost-5-ene-7,17-dione
-
521-17-5
androst-5-ene-3β,17β-diol
-
63015-10-1
3β-Hydroxy-17-hydrazono-androsten-(5)